OSR Health (OSRHW) Amortizatization of Intangibles (2024 - 2026)
OSR Health (OSRHW) posted Amortizatization of Intangibles of $2.4 million for Q1 2026, up 5.67% sequentially from $2.3 million in Q4 2025, and up 6.38% YoY from $2.3 million in Q1 2025.
OSR Health (OSRHW) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
OSR Health has reported Amortizatization of Intangibles for 3 years, with the latest figure at $2.4 million in Q1 2026.
- Quarterly Amortizatization of Intangibles rose 6.38% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (up 4.23% YoY) and the FY2025 annual result came in at $9.3 million, down 3.98% from the prior year.
- Amortizatization of Intangibles advanced to $2.4 million in Q1 2026 per OSRHW's latest filing, from $2.3 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $2.9 million in Q1 2024 and troughed at $1.2 million in Q4 2024.
- A 3-year average of $2.4 million and a median of $2.4 million in 2025 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 91.39% in 2025, down 21.52% in 2025.
- Over 3 years, Amortizatization of Intangibles stood at $1.2 million in 2024, then surged by 91.39% to $2.3 million in 2025, then climbed by 5.67% to $2.4 million in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $2.4 million, $2.3 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | - |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 678,000.00 |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 2.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.42 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 2.81 Mn |
| Jun 30, 2024 | 2.81 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.90 Mn |